SCHEMBL26260050

SCHEMBL26260050

COc1ccc2c(-c3cncs3)c(OC)cc(-c3cncs3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IMPDH2 P12268 2/20 0.43
▸ IMPDH1 P20839 1/20 0.43
▸ LRRK2 Q5S007 2/20 0.40
▸ CYP11B2 P19099 3/20 0.38
▸ CYP19A1 P11511 2/20 0.38
▸ PDE7A Q13946 2/20 0.37
▸ PDE3A Q14432 2/20 0.37
▸ PDE10A Q9Y233 2/20 0.37
▸ AAK1 Q2M2I8 1/20 0.36
▸ CYP1A1 P04798 3/20 0.36
▸ CYP1B1 Q16678 3/20 0.36
▸ CYP11B1 P15538 1/20 0.35
▸ BDKRB2 P30411 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ CLK1 P49759 2/20 0.34
▸ CDK5 Q00535 2/20 0.34
▸ DYRK1A Q13627 2/20 0.34
▸ CDK5R1 Q15078 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26260088 0.80 HIF1A (0.41) IMPDH2IMPDH1LRRK2PDE7APDE3A
SCHEMBL26259491 0.76 MEN1 (0.47) KDM4EMAPTRAB9A
SCHEMBL27404970 0.72 PDE7A (0.51) IMPDH2IMPDH1LRRK2PDE7APDE3A
SCHEMBL26260037 0.71 CYP11B1 (0.53) CYP11B2CYP1A1CYP1B1CYP11B1KDM4E
SCHEMBL26259504 0.70 MAPK13 (0.46) CYP11B2CYP1A1CYP1B1CYP11B1KDM4E
SCHEMBL26260054 0.68 MAPT (0.41) CDK5DYRK1ACDK5R1KDM4EMAPT
SCHEMBL26260019 0.68 POLB (0.47) PDE10ACYP1A1CYP1B1KDM4EMAPT
SCHEMBL26259500 0.68 PDE4A (0.43) CYP1A1CYP1B1RAB9ACYP1A2ABL1
SCHEMBL26260114 0.68 IMPDH2 (0.38) IMPDH2IMPDH1LRRK2BDKRB2
SCHEMBL6037961 0.68 APP (0.55) CYP19A1MAPTRAB9ACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 IMPDH2 4066/4885IMPDH1 3713/4885LRRK2 515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback